0.6
[1]. Betsy T Kren, et al. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase survival kinases as RNA interference targets for triple negative breast cancer therapy. Breast Cancer Res. 015:17:19.

H317-H31-H1
P61-P61-P7-P7-P73-P0-P0-P30+P35-P30+P35
361
![]()
![]()